RAPT Therapeutics, Inc. (RAPT) Equity Ratio (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Equity Ratio for 5 consecutive years, with 0.88 as the latest value for Q3 2024.
- Quarterly Equity Ratio rose 1.77% to 0.88 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.88 through Sep 2024, up 1.77% year-over-year, with the annual reading at 0.85 for FY2023, 7.89% down from the prior year.
- Equity Ratio hit 0.88 in Q3 2024 for RAPT Therapeutics, up from 0.86 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.94 in Q2 2021 to a low of 0.84 in Q1 2024.
- Historically, Equity Ratio has averaged 0.89 across 5 years, with a median of 0.88 in 2024.
- Biggest five-year swings in Equity Ratio: grew 8.79% in 2021 and later dropped 7.89% in 2023.
- Year by year, Equity Ratio stood at 0.88 in 2020, then rose by 7.15% to 0.94 in 2021, then fell by 1.85% to 0.92 in 2022, then decreased by 7.89% to 0.85 in 2023, then increased by 3.8% to 0.88 in 2024.
- Business Quant data shows Equity Ratio for RAPT at 0.88 in Q3 2024, 0.86 in Q2 2024, and 0.84 in Q1 2024.